NASDAQ: SLN
Silence Therapeutics PLC Stock Ownership - Who owns Silence Therapeutics?

Insider buying vs selling

Have Silence Therapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLN insiders and whales buy or sell their stock.

SLN Shareholders

What type of owners hold Silence Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Iain Ross0.03%39,942$563.18kInsider
Craig A. Tooman0.02%33,486$472.15kInsider
James Edegolightly0.01%15,000$211.50kInsider
Steven J. Romano0.01%12,993$183.20kInsider
Michael H. Davidson0.01%12,993$183.20kInsider
David Lemus0.01%7,527$106.13kInsider
Sirenl0.00%3,311$46.69kInstitution
Siren LLC0.00%3,311$46.69kInstitution
Tcg Crossover Management LLC0.00%3,034$42.78kInstitution
Tcgcro0.00%3,034$42.78kInstitution

1 of 3

SLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLN0.02%0.09%
AGMB0.05%0.09%
VSTM0.11%55.30%Net SellingNet Selling
SGMT0.08%35.18%Net SellingNet Selling
ASMB0.09%63.58%Net BuyingNet Buying

Silence Therapeutics Stock Ownership FAQ

Who owns Silence Therapeutics?

Silence Therapeutics (NASDAQ: SLN) is owned by 0.02% institutional shareholders, 0.09% Silence Therapeutics insiders, and 99.90% retail investors. Iain Ross is the largest individual Silence Therapeutics shareholder, owning 39,942.00 shares representing 0.03% of the company. Iain Ross's Silence Therapeutics shares are currently valued at $563.18k.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.